Bicycle Therapeutics Reports Lower Q3 2026 Net Loss
Story updates
11:13:38 AM UTC
SquawkNews
Bicycle Therapeutics reported third-quarter 2026 collaboration revenue of $34.1 million and a net loss of $10.5 million, compared with a $59.1 million net loss a year earlier. The company had $469.9 million in cash and cash equivalents at September 30, 2026, and expects its cash runway to extend in…
11:13:41 AM UTC
SquawkNews
UK's Bicycle Therapeutics Q3 loss narrows as expenses fall
11:21:44 AM UTC
SquawkNews
Bicycle Therapeutics reported third-quarter 2026 collaboration revenue of $34.06 million, up 190.2% from the prior-year quarter, and a net loss of $10.48 million, narrower than the $59.1 million loss a year earlier. Diluted loss per share was $0.15, compared with $0.85.Financial Highlights¹ Reporte…